These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38506237)

  • 1. Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor.
    Deng G; Zhu D; Du Z; Xue Y; Song H; Li Y
    Cancer Med; 2024 Mar; 13(6):e7110. PubMed ID: 38506237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
    Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
    Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Miyamoto N; Takenaka Y; Sudo T; Eguchi H; Tanaka H; Fukusumi T; Takemoto N; Suzuki M; Inohara H
    Acta Otolaryngol; 2023 Oct; 143(10):925-930. PubMed ID: 38059478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
    Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
    Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram Based on Body Composition and Prognostic Nutritional Index Predicts Survival After Curative Resection of Gastric Cancer.
    Tao C; Hong W; Yin P; Wu S; Fan L; Lei Z; Yu Y
    Acad Radiol; 2024 May; 31(5):1940-1949. PubMed ID: 37981487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes.
    Chen L; Sun H; Zhao R; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Song H; Li X
    Front Pharmacol; 2022; 13():836958. PubMed ID: 35308215
    [No Abstract]   [Full Text] [Related]  

  • 9. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
    Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
    BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor.
    Deng GM; Song HB; Du ZZ; Xue YW; Song HJ; Li YZ
    World J Gastroenterol; 2024 Feb; 30(8):863-880. PubMed ID: 38516238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
    Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
    Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery].
    Zhang Q; Song HF; Ma BL; Zhang ZN; Zhou CH; Li AL; Liu J; Liang L; Zhu SY; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):149-155. PubMed ID: 36718704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study.
    Han Y; Wu J; Ji R; Tan H; Tian S; Yin J; Xu J; Chen X; Liu W; Cui H
    BMC Cancer; 2023 Aug; 23(1):751. PubMed ID: 37580693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with Nivolumab.
    Hu Q; Kudo K; Yukaya T; Hasuda H; Nakanishi R; Nakanoko T; Ando K; Ota M; Kimura Y; Koga T; Kusumoto T; Oki E; Yoshizumi T
    Oncology; 2024 Sep; ():1-9. PubMed ID: 39265563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.
    Park SH; Lee S; Song JH; Choi S; Cho M; Kwon IG; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Noh SH; Choi YY
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):620-625. PubMed ID: 31668977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
    Li P; Lai Y; Tian L; Zhou Q
    Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction.
    Lei W; Wang W; Qin S; Yao W
    Sci Rep; 2024 Jul; 14(1):17511. PubMed ID: 39080372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geriatric nutritional risk index predicts the prognosis of gastric cancer patients treated with immune checkpoint inhibitors.
    Liu B; Zhang L
    Medicine (Baltimore); 2024 Apr; 103(17):e37863. PubMed ID: 38669385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.